ArticleJournal of clinical & translational endocrinology2021

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective.

Adnan Zahid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.